Fluorescence quantitative PCR detection of WT1 gene expression in peripheral blood of patients with acute leukemias and its clinical implications.
- Author:
Bo BAI
1
;
Hong-Wei WANG
;
Yong-Qun XU
;
Hei-Nu YANG
;
Zhen-Hua QIAO
Author Information
1. Department of Hematology, The Second Hospital of Shanxi Medical University, Taiyuan 030001, China.
- Publication Type:Journal Article
- MeSH:
Acute Disease;
Adolescent;
Adult;
Aged;
Biomarkers, Tumor;
genetics;
Child;
Female;
Gene Expression Regulation, Leukemic;
Humans;
Leukemia;
blood;
genetics;
pathology;
Male;
Middle Aged;
Neoplasm, Residual;
blood;
diagnosis;
genetics;
Reproducibility of Results;
Reverse Transcriptase Polymerase Chain Reaction;
methods;
Sensitivity and Specificity;
WT1 Proteins;
genetics
- From:
Journal of Experimental Hematology
2005;13(4):610-614
- CountryChina
- Language:Chinese
-
Abstract:
To elucidate the expression of WT1 in all types of leukemias and its implications for monitoring minimal residual disease in patients with acute leukemia, the peripheral blood from 55 leukemia patients and 10 normal voluteer was detected by using FQ-RT-PCR. Follow-up monitoring of WT1 expression of peripheral blood was performed for 20 patients with acute leukemia. The results showed that the expression of WT1 gene in all types of leukemias was significantly higher than that in normal control (P < 0.001). For ANLL and ALL patients, the survival time in the group of WT1 6.8 x 10(-3), (P = 0.027). Follow-up detection of the expression of WT1 in peripheral blood samples from 20 acute leukemia patients, 7 cases relapsed after complete remission has been done. In 5 of 7 relapsed patients, the expression of WT1 had obviously increased about 2 - 3 months before clinical relapse became apparent. It is concluded that the established FQ-RT-PCR method is accurate and specific. The expression of WT1 gene is relatively high in all types of leukemias compared with normal peripheral blood cells, the higher WT1 expression may associate with poor prognosis in acute leukemia, and the dynamics of WT1 level correlate with the disease status. The quantitative assessment of WT1 expression in peripheral blood samples by FQ-RT-PCR may be a useful tool for monitoring minimal residual disease.
